Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs
Antonia MR Franco,1 Iryna Grafova,2 Fabiane V Soares,1,3 Gennaro Gentile,4 Claudia DC Wyrepkowski,1,3 Marcos A Bolson,5 Ézio Sargentini Jr,5 Cosimo Carfagna,4 Markku Leskelä,2 Andriy Grafov2 1Laboratory of Leishmaniasis and Chagas Disease, National Institute of Amazonian Researc...
Guardado en:
Autores principales: | Franco AMR, Grafova I, Soares FV, Gentile G, Wyrepkowski CDC, Bolson MA, Sargentini Jr E, Carfagna C, Leskelä M, Grafov A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02e4d814a6c5482a86cd7d94b21ae529 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
por: Muhammad Farooq, et al.
Publicado: (2021) -
Leishmaniasis Recidivans in Rural Venezuela
por: Ariadna Perez Sanchez, et al.
Publicado: (2020) -
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis
por: Lanza JS, et al.
Publicado: (2016) -
Antimony and Nickel Impurities in Blue and Green Copper Pigments
por: Sylwia Svorová Pawełkowicz, et al.
Publicado: (2021) -
Molecular Preadaptation to Antimony Resistance in <named-content content-type="genus-species">Leishmania donovani</named-content> on the Indian Subcontinent
por: F. Dumetz, et al.
Publicado: (2018)